MENU
NMRA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neumora Therapeutics (NMRA) Earnings Date & Reports

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed... Show more

A.I. Advisor
published Earnings

NMRA is expected to report earnings to rise 36.36% to -44 cents per share on October 29

Neumora Therapeutics NMRA Stock Earnings Reports
Q3'25
Est.
$-0.45
Q2'25
Beat
by $0.12
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.25
Q3'24
Beat
by $0.20
The last earnings report on August 06 showed earnings per share of -33 cents, beating the estimate of -44 cents. With 888.89K shares outstanding, the current market capitalization sits at 263.97M.
View a ticker or compare two or three
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NMRA showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
490 Arsenal Way
Phone
+1 857 760-0900
Employees
124
Web
https://www.neumoratx.com